Flex Ltd. insider sale: 15,000 shares at weighted avg prices

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Flex Ltd. (FLEX) insider transaction: The Chief Commercial Officer reported open‑market sales totaling 15,000 ordinary shares on 10/28/2025 under a Rule 10b5‑1(c) trading plan adopted on June 17, 2025. The sales were executed in three tranches at weighted average prices of $64.0007, $64.4348, and $65.3191, with disclosed price ranges from $63.28 to $65.40. Following these transactions, the reporting person beneficially owned 241,198 shares directly. Holdings include unvested RSUs scheduled to vest between 2026 and 2027.

Insights

Routine insider sale via 10b5-1; neutral signal.

The CCO disclosed sales of 15,000 Flex shares executed on 10/28/2025 pursuant to a pre‑arranged Rule 10b5‑1(c) plan. Weighted average prices were $64.0007, $64.4348, and $65.3191, with ranges from $63.28 to $65.40, indicating typical market execution.

Post‑transaction beneficial ownership stands at 241,198 shares, which includes unvested RSUs with vesting dates into 2027. As a pre‑planned sale by a single officer, this is administrative in nature; actual impact depends on broader trading activity and future disclosures.

Insider Trade Summary

Net Seller: 15,000 shares ($963,835)

Net Sell 3 txns

Insider Hartung Michael P

Role Chief Commercial Officer

Sold 15,000 shs ($964K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	6,881	$64.0007	$440K
Sale	Ordinary Shares	7,780	$64.4348	$501K
Sale	Ordinary Shares	339	$65.3191	$22K

Holdings After Transaction: Ordinary Shares — 249,317 shares (Direct)

Footnotes (1)

The sale(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 17, 2025. Price reflects weighted average sales price; actual sales prices ranged from $63.28 to $64.279. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. Price reflects weighted average sales price; actual sales prices ranged from $64.28 to $65.27. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. Price reflects weighted average sales price; actual sales prices ranged from $65.28 to $65.40. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. Includes the following: (1) 18,768 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 21,964 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; (3) 14,574 unvested RSUs, which will vest on June 14, 2026; (4) 10,532 unvested RSUs, which will vest in two equal annual installments beginning on August 15, 2026; and (5) 72,578 unvested RSUs, which will vest on September 25, 2027. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited.

Form 4 Insider Transactions: What Each Field Means →

10/28/2025 - 08:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hartung Michael P

(Last)

(First)

(Middle)

C/O FLEXTRONICS INTERNATIONAL USA, INC.

12515-8 RESEARCH BLVD, SUITE 300

(Street)

AUSTIN

78759

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
FLEX LTD. [ FLEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	10/28/2025		S⁽¹⁾		6,881	D	$64.0007⁽²⁾	249,317	D
Ordinary Shares	10/28/2025		S⁽¹⁾		7,780	D	$64.4348⁽³⁾	241,537	D
Ordinary Shares	10/28/2025		S⁽¹⁾		339	D	$65.3191⁽⁴⁾	241,198⁽⁵⁾⁽⁶⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 17, 2025.

2. Price reflects weighted average sales price; actual sales prices ranged from $63.28 to $64.279. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

3. Price reflects weighted average sales price; actual sales prices ranged from $64.28 to $65.27. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

4. Price reflects weighted average sales price; actual sales prices ranged from $65.28 to $65.40. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

5. Includes the following: (1) 18,768 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 21,964 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; (3) 14,574 unvested RSUs, which will vest on June 14, 2026; (4) 10,532 unvested RSUs, which will vest in two equal annual installments beginning on August 15, 2026; and (5) 72,578 unvested RSUs, which will vest on September 25, 2027.

6. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited.

Remarks:

	/s/ Michael P. Hartung, by Kristine Murphy as attorney-in-fact	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did FLEX’s CCO report on Form 4?

A sale of 15,000 ordinary shares on 10/28/2025 executed under a Rule 10b5‑1(c) trading plan.

What prices were the FLEX shares sold at?

Weighted averages were $64.0007, $64.4348, and $65.3191, with price ranges from $63.28 to $65.40.

How many FLEX shares does the insider own after the sale?

Beneficial ownership was 241,198 shares directly after the reported transactions.

Was this an open‑market sale or part of a plan?

The sales were executed under a Rule 10b5‑1(c) trading plan adopted on June 17, 2025.

Do the holdings include RSUs?

Yes. Beneficial ownership includes unvested RSUs with vesting schedules extending into 2027.